These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33926024)

  • 1. In Vivo Imaging of Thyroid Cancer with
    Galli F; Varani M; Lauri C; Campagna G; Balogh L; Weintraub BD; Szkudlinski MW; Bartolazzi A; Manni I; Piaggio G; Signore A
    J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33926024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99m)Tc-labeled-rhTSH analogue (TR1401) for imaging poorly differentiated metastatic thyroid cancer.
    Galli F; Manni I; Piaggio G; Balogh L; Weintraub BD; Szkudlinski MW; Fremont V; Dierckx RA; Signore A
    Thyroid; 2014 Aug; 24(8):1297-308. PubMed ID: 24801227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and radioiodide.
    Reinfelder J; Maschauer S; Foss CA; Nimmagadda S; Fremont V; Wolf V; Weintraub BD; Pomper MG; Szkudlinski MW; Kuwert T; Prante O
    Thyroid; 2011 Jul; 21(7):783-92. PubMed ID: 21568725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [
    Gimblet GR; Houson HA; Whitt J; Reddy P; Copland JA; Kenderian SS; Szkudlinski MW; Jaskula-Sztul R; Lapi SE
    Mol Pharm; 2024 Aug; 21(8):3889-3896. PubMed ID: 38976794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of thyroid-stimulating hormone on 18F-fluorodeoxyglucose and 99mTc-methoxyisobutylisonitrile uptake in human poorly differentiated thyroid cancer cells in vitro.
    Kim CH; Yoo IeR; Chung YA; Park YH; Kim SH; Sohn HS; Chung SK
    Ann Nucl Med; 2009 Feb; 23(2):131-6. PubMed ID: 19225935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of
    Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D
    Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
    Gimblet GR; Whitt J; Houson HA; Lin D; Guenter R; Rao TC; Wang D; Ness J; Gonzalez ML; Murphy MS; Gillis A; Chen H; Copland JA; Kenderian SS; Lloyd RV; Szkudlinski MW; Lapi SE; Jaskula-Sztul R
    Surgery; 2024 Jan; 175(1):199-206. PubMed ID: 37919223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Imaging of Tumor PD-L1 Expression Using [
    Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
    Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of
    Okudan B; Seven B; Gülaldı NCM; Çapraz M; Açıkgöz Y
    Curr Med Imaging; 2022; 18(4):404-408. PubMed ID: 34749623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
    J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer - a preliminary study.
    Kolodziej M; Saracyn M; Lubas A; Brodowska-Kania D; Mazurek A; Dziuk M; Dymus J; Kaminski G
    Nucl Med Rev Cent East Eur; 2021; 24(2):63-69. PubMed ID: 34382670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of
    Zheng J; Miao W; Huang C; Lin H
    Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
    Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
    Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of [
    Xu Q; Liu R; Wang J; Huang Y; Li S; Zhang L; Wang F
    Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
    Grabellus F; Nagarajah J; Bockisch A; Schmid KW; Sheu SY
    Clin Nucl Med; 2012 Feb; 37(2):121-7. PubMed ID: 22228332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a New
    Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.